integrating immune strategies for Translational Research in Oncology and Neurology

Inflammation represents a common hallmark shared across different non-communicable diseases (NCD) such as auto-immune disease, cancer and neurodegeneration. In Luxembourg, a considerable translational research expertise has been built up based on aberrant immune mechanisms bridging between these disease domains. i2TRON will leverage on this fundamental and clinical research expertise to train next generation translational scientists with the aim to advance our mechanistic insight on selected prototypic NCDs. Such insights will lead to discoveries of new biomarkers and therapeutic targets of NCDs, and facilitate translation into novel treatment strategies.